Literature DB >> 9450794

Beta-thalassaemia intermedia: is it possible consistently to predict phenotype from genotype?

P J Ho1, G W Hall, L Y Luo, D J Weatherall, S L Thein.   

Abstract

Eighty-seven patients with beta thalassaemia of intermediate severity were investigated in our Unit to determine whether it is possible to consistently predict phenotypic severity from genotypic factors. The subjects were from the following ethnic backgrounds: Asian Indian (35.1%), Middle Eastern (24.3%), Mediterranean (21.6%), Northern European (14.9%) and South-East Asian/Chinese (4.1%). There was a wide spectrum of phenotypic severity; 49 had mild disease, 22 moderate and 16 severe disease. 22/87 patients had inherited only a single copy of a beta-thalassaemia allele, of whom 11 had also co-inherited triplicated alpha genes (alpha alpha alpha/alpha alpha or alpha alpha alpha/alpha alpha alpha) and seven had dominantly inherited beta thalassaemia. In four of the heterozygotes no explanation was found for the thalassaemia-intermedia phenotype. 65/87 patients were homozygous or compound heterozygous for 26 mutations (40 genotypes) which ranged from very mild beta+ to beta0 thalassaemia alleles. All patients with two mild or very mild beta+ thalassaemia alleles had mild to moderate disease. Although concurrent inheritance of extra alpha genes with heterozygous beta thalassaemia results in thalassaemia intermedia, the disease is mild. Co-inheritance of alpha thalassaemia as a modulating factor was not evident in this cohort of patients. Presence of the in-cis Xmn I-Ggamma site was a modulating factor but insufficient to explain the high fetal haemoglobin levels encountered. In conclusion, apart from the two categories of triplicated alpha genes with heterozygous beta thalassaemia and inheritance of mild beta+ thalassaemia alleles, it was not possible to consistently predict phenotype from alpha and beta genotypes alone, due to the influence of modulating factors, some implicated (such as inheritance of HPFH determinants) and others as yet unidentified.

Entities:  

Mesh:

Year:  1998        PMID: 9450794     DOI: 10.1046/j.1365-2141.1998.00519.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  28 in total

1.  Evidence of genetic interaction between the beta-globin complex and chromosome 8q in the expression of fetal hemoglobin.

Authors:  Chad P Garner; Thanusak Tatu; Steve Best; Lisa Creary; Swee Lay Thein
Journal:  Am J Hum Genet       Date:  2002-01-30       Impact factor: 11.025

Review 2.  Control of fetal hemoglobin: new insights emerging from genomics and clinical implications.

Authors:  Swee Lay Thein; Stephan Menzel; Mark Lathrop; Chad Garner
Journal:  Hum Mol Genet       Date:  2009-10-15       Impact factor: 6.150

3.  Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype.

Authors:  Leslie Weber; Giacomo Frati; Tristan Felix; Giulia Hardouin; Antonio Casini; Clara Wollenschlaeger; Vasco Meneghini; Cecile Masson; Anne De Cian; Anne Chalumeau; Fulvio Mavilio; Mario Amendola; Isabelle Andre-Schmutz; Anna Cereseto; Wassim El Nemer; Jean-Paul Concordet; Carine Giovannangeli; Marina Cavazzana; Annarita Miccio
Journal:  Sci Adv       Date:  2020-02-12       Impact factor: 14.136

4.  Correction of β654-thalassaemia mice using direct intravenous injection of siRNA and antisense RNA vectors.

Authors:  Shu-Yang Xie; Wei Li; Zhao-Rui Ren; Shu-Zhen Huang; Fanyi Zeng; Yi-Tao Zeng
Journal:  Int J Hematol       Date:  2011-03-04       Impact factor: 2.490

Review 5.  Beta-thalassaemia prototype of a single gene disorder with multiple phenotypes.

Authors:  Swee Lay Thein
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

6.  Multiplex amplification refractory mutation system (MARMS) for the detection of β-globin gene mutations among the transfusion-dependent β-thalassemia Malay patients in Kelantan, Northeast of Peninsular Malaysia.

Authors:  Sarifah Hanafi; Rosline Hassan; Rosnah Bahar; Wan Zaidah Abdullah; Muhammad Farid Johan; Noor Diana Rashid; Nurul Fatihah Azman; Ariffin Nasir; Syahzuwan Hassan; Rahimah Ahmad; Azizah Othman; Mohd Ismail Ibrahim; Surianti Sukeri; Sarina Sulong; Surini Yusoff; Nor Sarwany Mohamad; Adil Hussein; Rozita Hassan; Narazah Yusoff; Badrul Hisyam Yahaya; Endom Ismail; Nik Khairuddin Nik Yussof; Sinari Salleh; Bin Alwi Zilfalil
Journal:  Am J Blood Res       Date:  2014-09-05

7.  Disruption of the Hbs1l-Myb locus causes hereditary persistence of fetal hemoglobin in a mouse model.

Authors:  Mikiko Suzuki; Hiromi Yamazaki; Harumi Y Mukai; Hozumi Motohashi; Lihong Shi; Osamu Tanabe; James Douglas Engel; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2013-02-19       Impact factor: 4.272

8.  The molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity.

Authors:  Wanqun Chen; Xinhua Zhang; Xuan Shang; Ren Cai; Liyan Li; Tianhong Zhou; Manna Sun; Fu Xiong; Xiangmin Xu
Journal:  BMC Med Genet       Date:  2010-02-25       Impact factor: 2.103

9.  Disease-associated mutations that alter the RNA structural ensemble.

Authors:  Matthew Halvorsen; Joshua S Martin; Sam Broadaway; Alain Laederach
Journal:  PLoS Genet       Date:  2010-08-19       Impact factor: 5.917

10.  Molecular basis of transfusion dependent beta-thalassemia major patients in Sabah.

Authors:  Lai Kuan Teh; Elizabeth George; Mei I Lai; Jin Ai Mary Anne Tan; Lily Wong; Patimah Ismail
Journal:  J Hum Genet       Date:  2013-12-26       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.